Insider Monitor Realtime Top 10
  1. Company List - S
  2. STML

Insider Trading activities at Stemline Therapeutics Inc (STML)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stemline Therapeutics Inc (STML) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Stemline Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1264587.

Total stock buying since 2014: $75,247.
Total stock sales since 2014: $12,103,559.
Total stock option exercises since 2014: $133,030.


8 insiders reported insider trading activities at Stemline Therapeutics Inc (STML):
▪ Insider trading activities of Zuerblis Kenneth J
▪ Insider trading activities of Rowinsky Eric K
▪ Insider trading activities of Bergstein Ivan
▪ Insider trading activities of Hoberman Kenneth
▪ Insider trading activities of Francomano Robert
▪ Insider trading activities of Bentsur Ron
▪ Insider trading activities of Forman Alan S
▪ Insider trading activities of Gionco David

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Stemline Therapeutics Inc (STML).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2020 0 $0 252,795 $1,440,532 0 $0
2019 2,000 $20,020 471,993 $5,856,667 0 $0
2018 0 $0 182,714 $2,961,363 0 $0
2017 0 $0 71,198 $669,409 0 $0
2016 0 $0 17,061 $85,344 0 $0
2015 0 $0 51,478 $714,689 32,526 $133,030
2014 5,000 $55,227 27,224 $375,555 0 $0

Table 2. Monthly summary of insider trading at Stemline Therapeutics Inc (STML).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-05 0 $0 272 $3,130 0 $0
2020-04 0 $0 65,142 $316,854 0 $0
2020-03 0 $0 101,614 $502,782 0 $0
2020-02 0 $0 50,400 $325,177 0 $0
2020-01 0 $0 35,367 $292,589 0 $0
2019-12 2,000 $20,020 109,527 $1,187,117 0 $0
2019-08 0 $0 35,010 $515,697 0 $0
2019-06 0 $0 103,431 $1,559,078 0 $0
2019-05 0 $0 25,817 $368,408 0 $0
2019-03 0 $0 108,504 $1,208,326 0 $0
2019-02 0 $0 76,157 $880,539 0 $0
2019-01 0 $0 13,547 $137,502 0 $0
2018-11 0 $0 26,296 $311,607 0 $0
2018-03 0 $0 88,264 $1,537,806 0 $0
2018-02 0 $0 49,864 $859,296 0 $0
2018-01 0 $0 18,290 $252,654 0 $0
2017-12 0 $0 11,983 $169,941 0 $0
2017-03 0 $0 8,859 $72,093 0 $0
2017-02 0 $0 37,653 $260,300 0 $0
2017-01 0 $0 12,703 $167,075 0 $0
2016-03 0 $0 9,097 $48,554 0 $0
2016-02 0 $0 4,747 $21,291 0 $0
2016-01 0 $0 3,217 $15,499 0 $0
2015-11 0 $0 12,235 $100,326 0 $0

Table 3. Detailed insider trading at Stemline Therapeutics Inc (STML)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-05-04 Francomano Robert (Chief Commercial Officer) Sale 272 11.51 3,130
2020-04-15 Bergstein Ivan (Chief Executive Officer) Sale 53,618 4.88 261,655
2020-04-01 Gionco David (Chief Accounting Officer) Sale 11,524 4.79 55,199
2020-03-16 Gionco David (Chief Accounting Officer) Sale 2,849 3.88 11,054
2020-03-10 Hoberman Kenneth (Chief Operating Officer) Sale 16,704 4.91 82,016
2020-03-10 Bergstein Ivan (Chief Executive Officer) Sale 36,542 4.92 179,786
2020-03-10 Gionco David (Chief Accounting Officer) Sale 8,846 4.92 43,522
2020-03-09 Francomano Robert (Chief Commercial Officer) Sale 1,266 5.00 6,330
2020-03-09 Hoberman Kenneth (Chief Operating Officer) Sale 9,487 5.08 48,193
2020-03-09 Bergstein Ivan (Chief Executive Officer) Sale 20,909 5.09 106,426
2020-03-09 Gionco David (Chief Accounting Officer) Sale 5,011 5.08 25,455
2020-02-25 Hoberman Kenneth (Chief Operating Officer) Sale 11,547 6.42 74,131
2020-02-25 Bergstein Ivan (Chief Executive Officer) Sale 24,642 6.42 158,201
2020-02-25 Gionco David (Chief Accounting Officer) Sale 9,147 6.43 58,815
2020-02-07 Francomano Robert (Chief Commercial Officer) Sale 5,064 6.72 34,030
2020-01-22 Hoberman Kenneth (Chief Operating Officer) Sale 22,139 7.02 155,415
2020-01-08 Hoberman Kenneth (Chief Operating Officer) Sale 13,228 10.37 137,174
2019-12-27 Francomano Robert (Chief Commercial Officer) Sale 116 10.48 1,215
2019-12-27 Hoberman Kenneth (Chief Operating Officer) Sale 2,022 10.48 21,190
2019-12-27 Bergstein Ivan (Chief Executive Officer) Sale 2,446 10.48 25,634
2019-12-27 Gionco David (Chief Accounting Officer) Sale 197 10.48 2,064
2019-12-26 Francomano Robert (Chief Commercial Officer) Sale 893 10.75 9,599
2019-12-26 Hoberman Kenneth (Chief Operating Officer) Sale 15,494 10.75 166,560
2019-12-26 Bergstein Ivan (Chief Executive Officer) Sale 18,744 10.75 201,498
2019-12-26 Gionco David (Chief Accounting Officer) Sale 1,511 10.75 16,243
2019-12-24 Francomano Robert (Chief Commercial Officer) Sale 1,412 10.97 15,489
2019-12-24 Hoberman Kenneth (Chief Operating Officer) Sale 24,477 10.97 268,512
2019-12-24 Bergstein Ivan (Chief Executive Officer) Sale 29,613 10.97 324,854
2019-12-24 Gionco David (Chief Accounting Officer) Sale 2,388 10.97 26,196
2019-12-23 Francomano Robert (Chief Commercial Officer) Sale 249 10.58 2,634
2019-12-23 Hoberman Kenneth (Chief Operating Officer) Sale 4,319 10.58 45,695
2019-12-23 Bergstein Ivan (Chief Executive Officer) Sale 5,225 10.58 55,280
2019-12-23 Gionco David (Chief Accounting Officer) Sale 421 10.58 4,454
2019-12-04 Forman Alan S (Director) Buy 1,000 9.73 9,730
2019-12-02 Forman Alan S (Director) Buy 1,000 10.29 10,290
2019-08-14 Bergstein Ivan (Chief Executive Officer) Sale 35,010 14.73 515,697
2019-06-26 Hoberman Kenneth (Chief Operating Officer) Sale 12,508 14.77 184,743
2019-06-26 Bergstein Ivan (Chief Executive Officer) Sale 16,994 14.77 251,001
2019-06-25 Hoberman Kenneth (Chief Operating Officer) Sale 25,500 15.07 384,285
2019-06-25 Bergstein Ivan (Chief Executive Officer) Sale 28,500 15.10 430,350
2019-06-24 Hoberman Kenneth (Chief Operating Officer) Sale 9,107 15.49 141,067
2019-06-24 Bergstein Ivan (Chief Executive Officer) Sale 10,822 15.49 167,632
2019-05-14 Hoberman Kenneth (Chief Operating Officer) Sale 25,817 14.27 368,408
2019-03-12 Hoberman Kenneth (Chief Operating Officer) Sale 981 11.04 10,830
2019-03-12 Bergstein Ivan (Chief Executive Officer) Sale 2,151 11.05 23,768
2019-03-12 Gionco David (Chief Accounting Officer) Sale 530 11.05 5,856
2019-03-11 Hoberman Kenneth (Chief Operating Officer) Sale 25,101 11.11 278,872
2019-03-11 Bergstein Ivan (Chief Executive Officer) Sale 55,073 11.11 611,861
2019-03-11 Gionco David (Chief Accounting Officer) Sale 13,492 11.11 149,896
2019-03-07 Hoberman Kenneth (Chief Operating Officer) Sale 2,995 11.36 34,023
2019-03-07 Bergstein Ivan (Chief Executive Officer) Sale 6,800 11.41 77,588
2019-03-07 Gionco David (Chief Accounting Officer) Sale 1,381 11.32 15,632
2019-02-25 Hoberman Kenneth (Chief Operating Officer) Sale 10,557 12.05 127,211
2019-02-25 Bergstein Ivan (Chief Executive Officer) Sale 22,905 12.03 275,547
2019-02-25 Gionco David (Chief Accounting Officer) Sale 8,563 12.03 103,012
2019-02-14 Bergstein Ivan (Chief Executive Officer) Sale 34,132 10.98 374,769
2019-01-08 Hoberman Kenneth (Chief Operating Officer) Sale 13,547 10.15 137,502
2018-11-26 Hoberman Kenneth (Chief Operating Officer) Sale 26,296 11.85 311,607
2018-03-13 Hoberman Kenneth (Chief Operating Officer) Sale 12,746 16.82 214,387
2018-03-12 Hoberman Kenneth (Chief Operating Officer) Sale 17,241 17.71 305,338
2018-03-12 Bergstein Ivan (Chief Executive Officer) Sale 37,857 17.68 669,122
2018-03-12 Gionco David (Chief Accounting Officer) Sale 9,183 17.74 162,906
2018-03-07 Hoberman Kenneth (Chief Operating Officer) Sale 3,027 16.55 50,096
2018-03-07 Bergstein Ivan (Chief Executive Officer) Sale 6,797 16.56 112,558
2018-03-07 Gionco David (Chief Accounting Officer) Sale 1,413 16.56 23,399
2018-02-27 Hoberman Kenneth (Chief Operating Officer) Sale 5,726 17.26 98,830
2018-02-27 Bergstein Ivan (Chief Executive Officer) Sale 13,407 17.26 231,404
2018-02-27 Gionco David (Chief Accounting Officer) Sale 4,584 17.26 79,119
2018-02-26 Hoberman Kenneth (Chief Operating Officer) Sale 5,300 17.61 93,333
2018-02-26 Bergstein Ivan (Chief Executive Officer) Sale 10,776 17.61 189,765
2018-02-26 Gionco David (Chief Accounting Officer) Sale 4,400 17.61 77,484
2018-02-15 Hoberman Kenneth (Chief Operating Officer) Sale 1,851 15.67 29,005
2018-02-15 Bergstein Ivan (Chief Executive Officer) Sale 3,820 15.80 60,356
2018-01-17 Gionco David (Chief Accounting Officer) Sale 4,250 13.43 57,077
2018-01-08 Hoberman Kenneth (Chief Operating Officer) Sale 14,040 13.93 195,577
2017-12-18 Hoberman Kenneth (Chief Operating Officer) Sale 40 14.75 590
2017-12-15 Hoberman Kenneth (Chief Operating Officer) Sale 11,943 14.18 169,351
2017-03-07 Hoberman Kenneth (Chief Operating Officer) Sale 2,342 8.16 19,110
2017-03-07 Bergstein Ivan (Chief Executive Officer) Sale 5,401 8.13 43,910
2017-03-07 Gionco David (Chief Accounting Officer) Sale 1,116 8.13 9,073
2017-02-28 Hoberman Kenneth (Chief Operating Officer) Sale 4,027 7.01 28,229
2017-02-28 Bergstein Ivan (Chief Executive Officer) Sale 10,480 7.01 73,464
2017-02-28 Gionco David (Chief Accounting Officer) Sale 2,986 7.01 20,931
2017-02-27 Hoberman Kenneth (Chief Operating Officer) Sale 4,000 6.97 27,880
2017-02-27 Bergstein Ivan (Chief Executive Officer) Sale 7,500 6.97 52,275
2017-02-27 Gionco David (Chief Accounting Officer) Sale 3,500 6.97 24,395
2017-02-16 Hoberman Kenneth (Chief Operating Officer) Sale 1,508 6.42 9,681
2017-02-16 Bergstein Ivan (Chief Executive Officer) Sale 3,652 6.42 23,445
2017-01-19 Gionco David (Chief Accounting Officer) Sale 3,593 11.46 41,175
2017-01-10 Hoberman Kenneth (Chief Operating Officer) Sale 9,110 13.82 125,900
2016-03-08 Hoberman Kenneth (Chief Operating Officer) Sale 2,412 5.34 12,880
2016-03-08 Bergstein Ivan (Chief Executive Officer) Sale 5,537 5.34 29,567
2016-03-08 Gionco David (Chief Accounting Officer) Sale 1,148 5.32 6,107
2016-02-17 Hoberman Kenneth (Chief Operating Officer) Sale 1,503 4.54 6,823
2016-02-17 Bergstein Ivan (Chief Executive Officer) Sale 3,244 4.46 14,468
2016-01-20 Gionco David (Chief Accounting Officer) Sale 46 4.69 215
2016-01-19 Gionco David (Chief Accounting Officer) Sale 3,171 4.82 15,284
2015-11-30 Bergstein Ivan (Chief Executive Officer) Sale 12,235 8.20 100,326
2015-04-27 Rowinsky Eric K (Chief Medical Officer) Sale 10,824 15.77 170,694
2015-03-19 Hoberman Kenneth (Chief Operating Officer) Sale 17,307 16.43 284,354
2015-03-19 Hoberman Kenneth (Chief Operating Officer) Option Ex 27,105 4.09 110,859
2015-03-18 Bentsur Ron (Director) Sale 1,388 16.12 22,374
2015-03-18 Bentsur Ron (Director) Option Ex 5,421 4.09 22,171
2015-02-18 Hoberman Kenneth (Chief Operating Officer) Sale 1,593 14.02 22,333
2015-02-18 Bergstein Ivan (Chief Executive Officer) Sale 3,180 14.02 44,583
2015-02-18 Rowinsky Eric K (Chief Medical Officer) Sale 1,640 13.99 22,943
2015-01-20 Gionco David (Chief Accounting Officer) Sale 3,311 14.22 47,082
2014-11-26 Bergstein Ivan (Chief Executive Officer) Sale 11,974 14.40 172,425
2014-09-03 Bergstein Ivan (Chief Executive Officer) Buy 2,000 11.05 22,108
2014-09-02 Hoberman Kenneth (Chief Operating Officer) Buy 2,000 10.99 21,976
2014-09-02 Zuerblis Kenneth J (Director) Buy 1,000 11.14 11,143
2014-05-21 Hoberman Kenneth (Chief Operating Officer) Sale 15,250 13.32 203,130

Insider trading activities including stock purchases, stock sales, and option exercises of STML listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stemline Therapeutics Inc (symbol STML, CIK number 1264587) see the Securities and Exchange Commission (SEC) website.



▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month




©2023, insider-monitor.com. All rights reserved.